ReviewCancers2025

Immune Checkpoint Inhibitors and Targeted Therapies in Early-Stage Non-Small-Cell Lung Cancer: State-of-the-Art and Future Perspectives.

Lucrezia Barcellini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.